Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Bone health in subjects with type 1 diabetes for more than 50 years.

Maddaloni E, D'Eon S, Hastings S, Tinsley LJ, Napoli N, Khamaisi M, Bouxsein ML, Fouda SM, Keenan HA.

Acta Diabetol. 2017 May;54(5):479-488. doi: 10.1007/s00592-017-0973-2. Epub 2017 Feb 25.

PMID:
28236093
2.

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.

Saremi A, Howell S, Schwenke DC, Bahn G, Beisswenger PJ, Reaven PD; VADT Investigators.

Diabetes Care. 2017 Apr;40(4):591-598. doi: 10.2337/dc16-1875. Epub 2017 Feb 1.

PMID:
28148544
3.

DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes.

Jaramillo R, Shuck SC, Chan YS, Liu X, Bates SE, Lim PP, Tamae D, Lacoste S, O'Connor TR, Termini J.

Chem Res Toxicol. 2017 Feb 20;30(2):689-698. doi: 10.1021/acs.chemrestox.6b00414. Epub 2017 Feb 3.

4.

Diabetic Retinopathy: Battling the Global Epidemic.

Das A.

Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6669-6682. doi: 10.1167/iovs.16-21031. No abstract available.

5.

Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.

van der Heyden JC, Birnie E, Mul D, Bovenberg S, Veeze HJ, Aanstoot HJ.

BMC Endocr Disord. 2016 Sep 9;16(1):49. doi: 10.1186/s12902-016-0129-3.

6.

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.

Saulnier PJ, Wheelock KM, Howell S, Weil EJ, Tanamas SK, Knowler WC, Lemley KV, Mauer M, Yee B, Nelson RG, Beisswenger PJ.

Diabetes. 2016 Dec;65(12):3744-3753. Epub 2016 Sep 8.

7.

Subjects With Extreme-Duration Type 1 Diabetes Exhibit No Structural or Functional Abnormality on Cardiac MRI.

Asghar O, Miller C, Ray S, Schmitt M, Malik RA.

Diabetes Care. 2016 Oct;39(10):e167-8. doi: 10.2337/dc16-0760. Epub 2016 Aug 3. No abstract available.

PMID:
27489337
8.
9.

Grape seed proanthocyanidin extract protects the retina against early diabetic injury by activating the Nrf2 pathway.

Sun Y, Xiu C, Liu W, Tao Y, Wang J, Qu YI.

Exp Ther Med. 2016 Apr;11(4):1253-1258. Epub 2016 Jan 29.

10.

Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.

Bai JW, Boulet G, Halpern EM, Lovblom LE, Eldelekli D, Keenan HA, Brent M, Paul N, Bril V, Cherney DZ, Weisman A, Perkins BA.

Cardiovasc Diabetol. 2016 Jan 25;15:14. doi: 10.1186/s12933-015-0318-9.

11.

PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.

Khamaisi M, Katagiri S, Keenan H, Park K, Maeda Y, Li Q, Qi W, Thomou T, Eschuk D, Tellechea A, Veves A, Huang C, Orgill DP, Wagers A, King GL.

J Clin Invest. 2016 Mar 1;126(3):837-53. doi: 10.1172/JCI82788. Epub 2016 Jan 25.

12.

Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

Javed S, Alam U, Malik RA.

Rev Diabet Stud. 2015 Spring-Summer;12(1-2):63-83. doi: 10.1900/RDS.2015.12.63. Epub 2015 Aug 10. Review.

13.

Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population.

Lee SI, Patel M, Jones CM, Narendran P.

Ther Adv Chronic Dis. 2015 Nov;6(6):347-74. doi: 10.1177/2040622315598502. Review.

14.

Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.

Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, Genuth S; DCCT/EDIC Research Group.

Cardiovasc Diabetol. 2015 Sep 5;14:118. doi: 10.1186/s12933-015-0266-4. Erratum in: Cardiovasc Diabetol. 2015;14:138.

15.

Cardiovascular disease protection in long-duration type 1 diabetes and sex differences.

He ZH, D'Eon SA, Tinsley LJ, Fitzgerald S, Hastings SM, Khamaisi M, Sun JK, Turek SJ, Schaefer EJ, King GL, Keenan HA.

Diabetes Care. 2015 May;38(5):e73-4. doi: 10.2337/dc15-0017. No abstract available.

16.

Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population.

Upadhyay R, Robay A, Fakhro K, Abi Khalil C, Zirie M, Jayyousi A, El-Shafei M, Kiss S, D'Amico DJ, Salit J, Staudt MR, O'Beirne SL, Chen X, Tuana B, Crystal RG, Ding H.

J Transl Med. 2015 Feb 15;13:61. doi: 10.1186/s12967-015-0411-6.

17.

Fracture risk in diabetic elderly men: the MrOS study.

Napoli N, Strotmeyer ES, Ensrud KE, Sellmeyer DE, Bauer DC, Hoffman AR, Dam TT, Barrett-Connor E, Palermo L, Orwoll ES, Cummings SR, Black DM, Schwartz AV.

Diabetologia. 2014 Oct;57(10):2057-65. doi: 10.1007/s00125-014-3289-6. Epub 2014 Jun 9.

18.

Diabetes-induced oxidative DNA damage alters p53-p21CIP1/Waf1 signaling in the rat testis.

Kilarkaje N, Al-Bader MM.

Reprod Sci. 2015 Jan;22(1):102-12. doi: 10.1177/1933719114533729. Epub 2014 May 14.

19.

Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes.

Hernandez SL, Gong JH, Chen L, Wu IH, Sun JK, Keenan HA, King GL.

Diabetes Care. 2014 Aug;37(8):2193-201. doi: 10.2337/dc13-2547. Epub 2014 Apr 29.

20.

The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.

Barzilay JI, Jablonski KA, Fonseca V, Shoelson SE, Goldfine AB, Strauch C, Monnier VM; TINSAL-T2D Research Consortium.

Diabetes Care. 2014 Apr;37(4):1083-91. doi: 10.2337/dc13-1527. Epub 2013 Nov 19.

Supplemental Content

Support Center